| 138 Intensive speech and language therapy in patients with chronic aphasia after stroke.
137 Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia.
136 Pharmacologic inhibition of Hsp90 to prevent GLT-1 degradation as an effective therapy for epilepsy.
135 In vivo imaging reveals that pregabalin inhibits cortical spreading depression and propagation to subcortical brain structures.
134 Early brain development in infants at high risk for autism spectrum disorder.
133 The impact of bilingualism on brain reserve and metabolic connectivity in Alzheimer's dementia.
132 Living near major roads and the incidence of dementia, Parkinson's disease, and multiple sclerosis: a population-based cohort study.
131 “Zombie” Outbreak Caused by the Synthetic Cannabinoid AMB-FUBINACA in New York.
130 Brain–Computer Interface–Based Communication in the Completely Locked-In State.
129 Contribution of propriospinal neurons to recovery of hand dexterity after corticospinal tract lesions in monkeys.
128 Ownership of an artificial limb induced by electrical brain stimulation.
127 A ketogenic diet rescues hippocampal memory defects in a mouse model of Kabuki syndrome.
126 Targeted clinical control of trauma patient coagulation through a thrombin dynamics model.
125 Cannabinoids affect CB1 receptors on the mitochondrial membranes in the brain, triggering a decrease in downstream cAMP-dependent signalling; this leads to a decrease in brain mitochondrial activity and to cannabinoid-induced amnesia.
124 Retrieval practice protects memory against acute stress.
123 Unique Behavioral and Neurochemical Effects Induced by Repeated Adolescent Consumption of Caffeine-Mixed Alcohol in C57BL/6 Mice.
122 Acute Neurologic Disorder from an Inhibitor of Fatty Acid Amide Hydrolase.
121 Safety and effectiveness of hormonal treatment versus hormonal treatment with vigabatrin for infantile spasms.
120 C-reactive protein concentrations across the mood spectrum in bipolar disorder: a systematic review and meta-analysis.
119 Imaging matrix metalloproteinase activity in multiple sclerosis as a specific marker of leukocyte penetration of the blood-brain barrier.